AMG 529 First in Human Study

Summary

A study to assess the safety and tolerability of AMG 529 following single, ascending doses administered subcutaneously (SC) or intravenously (IV) in healthy adults.

Timeline

Start

2017-05-15

Primary completion

2017-11-17

Completion

2017-11-17

Drugs

Indications